I agree that this site is using cookies. You can find further informations here.
X
Blancas, Isabel
49  results:
Articles (Online) X
?
1

Abemaciclib for treating patients with HR+/HER2- metastatic..:

Blancas, Isabel ; Grosjean, Jessica ; Pedersini, Rebecca...
Future Oncology.  , 2024
Link: https://doi.org/10.1080/..
 
?
2

Preventing alpelisib-related hyperglycaemia in HR+/HER2−/PI..:

Llombart-Cussac, Antonio ; Pérez-Garcia, José Manuel ; Ruiz Borrego, Manuel...
eClinicalMedicine.  71 (2024)  - p. 102520 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Autologous patient-derived exhausted nano T-cells exploit t..:

Blaya-Cánovas, José L. ; Griñán-Lisón, Carmen ; Blancas, Isabel...
Molecular Cancer.  23 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
4

HER2/neu 655 polymorphism, trastuzumab-induced cardiotoxici..:

Blancas, Isabel ; Linares-Rodríguez, Marina ; Martín-Bravo, Celia..
Clinical and Translational Oncology.  , 2024
Link: https://doi.org/10.1007/..
 
?
5

Retrospective registry of patients with locally advanced/me..:

Chavarría Piudo, Natalia ; Blancas, Isabel ; González Flores, Encarna...
Clinical and Translational Oncology.  , 2024
Link: https://doi.org/10.1007/..
 
?
6

Novel Genetic Variants Explaining Severe Adverse Drug Event..:

Díaz-Villamarín, Xando ; Martínez-Pérez, María ; Nieto-Sánchez, María Teresa...
Pharmaceutics.  16 (2024)  7 - p. 956 , 2024
Link: https://doi.org/10.3390/..
 
?
7

The Predictive Value of Blood-Derived Exosomal miRNAs as Bi..:

Linares-Rodríguez, Marina ; Blancas, Isabel ; Rodríguez-Serrano, Fernando
Clinical Breast Cancer.  , 2024
Link: https://doi.org/10.1016/..
 
?
8

SEOM–GEICAM–SOLTI clinical guidelines in advanced breast ca..:

Garcia-Saenz, Jose Angel ; Blancas, Isabel ; Echavarria, Isabel...
Clinical and Translational Oncology.  25 (2023)  9 - p. 2665-2678 , 2023
Link: https://doi.org/10.1007/..
 
?
9

Correction to: SEOM–GEICAM–SOLTI clinical guidelines in adv..:

Garcia-Saenz, Jose Angel ; Blancas, Isabel ; Echavarria, Isabel...
Clinical and Translational Oncology.  25 (2023)  9 - p. 2759-2759 , 2023
Link: https://doi.org/10.1007/..
 
?
10

TGFβ Governs the Pleiotropic Activity of NDRG1 in Triple-Ne..:

López-Tejada, Araceli ; Griñán-Lisón, Carmen ; González-González, Adrián...
International Journal of Biological Sciences.  19 (2023)  1 - p. 204-224 , 2023
Link: https://doi.org/10.7150/..
 
?
11

Neoadjuvant palbociclib plus either giredestrant or anastro..:

Hurvitz, Sara A ; Bardia, Aditya ; Quiroga, Vanesa...
The Lancet Oncology.  24 (2023)  9 - p. 1029-1041 , 2023
Link: https://doi.org/10.1016/..
 
?
12

Discovery of a synthetic taiwaniaquinoid with potent in vit..:

Mut-Salud, Nuria ; Guardia, Juan J. ; Fernández, Antonio...
Biomedicine & Pharmacotherapy.  168 (2023)  - p. 115791 , 2023
Link: https://doi.org/10.1016/..
 
?
13

HOPE (SOLTI-1903) breast cancer study: real-world, patient-..:

Olivera-Salguero, Rubén ; Seguí, Elia ; Cejalvo, Juan Miguel...
Frontiers in Oncology.  13 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
14

Early increase in tamoxifen dose in CYP2D6 poor metaboliser..:

Blancas, Isabel ; Linares-Rodríguez, Marina ; Martínez de Dueñas, Eduardo...
The Breast.  69 (2023)  - p. 342-348 , 2023
Link: https://doi.org/10.1016/..
 
?
15

Nanomedicine as a Promising Tool to Overcome Immune Escape ..:

Navarro-Ocón, Alba ; Blaya-Cánovas, Jose L. ; López-Tejada, Araceli...
Pharmaceutics.  14 (2022)  3 - p. 505 , 2022
Link: https://doi.org/10.3390/..
 
1-15